High hopes for low-priority drug trials
Not every pipeline drug can get blockbuster funding – but there are ways to breathe new life into neglected products
Read More
Search Results for: Ben van der Schaaf
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
